Demand for Pulse Oximeters and Impact of COVID-19……..
The global pulse oximeters market size is expected to reach USD 3.2 billion by 2027, expanding at a
CAGR of 6.4%, based on a new report by Grand View Research, Inc. Technological
advancement in design and development of pulse oximeter is expected to boost
market growth during the forecast period. Market players are introducing
devices that are more compact, portable, ease to use, accurate, and efficient.
For instance, in May 2020, Masimo received FDA clearance for its first
tetherless SET pulse oximeter, Radius PPG.
With Covid-19 infections rising globally, the
apprehension regarding a shortage of essential life-saving devices and other
essential medical supplies in order to prevent the spread of this pandemic and
provide optimum care to the infected also widens. In addition, till a
pharmacological treatment is developed, ventilators act as a vital treatment
preference for the COVID-19 patients, who may require critical care. Moreover,
there is an urgent need for a rapid acceleration in the manufacturing process
for a wide range of test-kits (antibody tests, self-administered, and others).
The report will account for Covid19 as a key market contributor.
Oxygen saturation monitors are
conventionally used in pre and postsurgical settings. They are used during
surgeries when patients are anesthetized. Increase in number of surgeries being
performed and focus on patient safety are among the key factors responsible for
increased use of the medical device during most procedures. These devices are
purchased once and require servicing, without the need for frequent
replacement. The use of oxygen saturation monitors in newborn screening can
boost the demand and procurement of these devices by hospitals for maternity
and pediatric care divisions.
The
market is fragmented with the presence of various global and regional
manufacturers. The market potential is driving numerous players to expand their
market share through acquisitions. Larger players tend to acquire sections
suitable for their product portfolio. For instance, in April 2020, Edwards
Lifesciences Corporation acquired COSMED in a USD.0 100 million deal. The
acquisition was made to combine COSMED’s FORE-SIGHT technology with Edward
Lifesciences HemoSphere, an advanced hemodynamic monitoring platform.
To Request Sample Copy of this report, click the link:
Pulse Oximeters Market Report
Highlights
·
The sale of fingertip pulse oximeters has
witnessed a significant spike since the first week of March 2020 due to
COVID-19 pandemic
·
Handheld pulse oximeters are expected to be
in high demand during the COVID-19 pandemic, as these devices are more accurate
and come with probes that can be used for individual patients to limit spread
of the virus
·
There is an upward trend in the use of
oxygen saturation monitors in homecare settings due to expansion of the
homecare market. Hospices and nursing care centers are procuring the medical
device to provide better care to their patients
·
North America held the largest share in the
market in 2020. Demand for oxygen saturation monitors is increasing in U.S. and
Canada due to high prevalence of Congenital Heart Diseases (CHD) in infants
·
In Asia Pacific, the market is anticipated
to witness significant growth during the forecast period. In countries such as
Australia and New Zealand, oxygen saturation monitors are part of the standard
patient observation procedures in hospitals and clinics. The device plays a
vital role in monitoring and treatment of respiratory diseases in newborns and
adults, as it provides independent information for a more comprehensive
respiratory assessment
·
The industry is also witnessing mergers,
acquisitions, and licensing agreements. For instance in April 2020, Philips
Respironics moved the rights for direct sales of pulse oximeter in homecare market
to Nonin Medical, an OEM manufacturer.
The global pulse oximeters market
size was valued at USD 1.9 billion in 2020 and is projected to grow at a
compound annual growth rate (CAGR) of 6.4% from 2020 to 2027. Increasing
emphasis on patient safety during anesthesia and demand for consistent vital
stats monitoring is expected to drive the growth of the market. Growing awareness
about patient monitoring and increase in target disease prevalence are expected
to boost market growth over the forecast period.
Government
initiatives and availability of new products are expected to further propel
market growth in the coming years. Pulse oximetry is mandatory for newborn
screening in around 43 states in U.S. It is also gaining popularity in other
parts of the world as it can help detect Congenital Heart Defects (CHD) and
other heart and respiratory conditions.
Growing
prevalence of COPD, sleep apnea, cardiac arrhythmia, ischemic conditions,
diabetes, hypertension, hyperlipidemia, and asthma is expected to be a major
market driver over the forecast period. Almost 2.7 million neonatal deaths are
recorded annually, out of which, 75.0% are from South Asia and Sub‐Saharan
Africa. Early detection of hypoxemic neonatal conditions using pulse oximetry
can lower the number of neonatal deaths to a large extent. Increased
penetration of pulse oximeters is anticipated to aid the situation, especially
in developing economies.
Continuous
monitoring of respiratory parameters is vital in patients infected with the
novel coronavirus. Thus, healthcare professionals are highly dependent on
medical devices, such as pulse oximeters and multi-parameter monitors, for
diagnosis, treatment, and management of COVID-19 symptoms. Furthermore, WHO
guidelines for clinical management of the disease have mentioned oxygen therapy
as a major intervention for patients with severe symptoms. Thus, government
bodies and healthcare organizations across the world have recommended
healthcare facilities to be equipped with medical oxygen systems and pulse
oximeters.
Have any Query? Ask our Experts:
Pulse Oximeters Market Segmentation
Grand View Research has segmented the
global pulse oximeters market based on type, end use,:
Pulse Oximeters Type Outlook (Revenue, USD Million, 2016
- 2027)
·
Fingertip
·
Handheld
·
Others
Pulse Oximeters End-use Outlook (Revenue, USD Million,
2016 - 2027)
·
Hospitals and Healthcare
Facilities
·
Homecare
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment